β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans

Liao, Weiting and Zhang, Yi and Wang, Jingxiao and Cui, Guofei and Evert, Matthias and Xu, Meng and Wu, Yanhui and Wang, Xue and Deng, Shanshan and Song, Xinhua and Monga, Satdarshan P. and Zhao, Jinqiu and Li, Qiu and Calvisi, Diego F. and Chen, Xin (2026) β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans. HEPATOLOGY, 83 (2). pp. 215-230. ISSN 0270-9139, 1527-3350

Full text not available from this repository. (Request a copy)

Abstract

Background and Aims:Hepatoblastoma (HB) is the predominant primary malignant liver tumor in childhood. Concomitant Yes-associated protein (YAP) and beta-Catenin activation occurs in most HB. However, the signaling pathways distinctively regulated by YAP and beta-Catenin protooncogenes in HB remain unexplored.Approach and Results:We engineered an inducible HB murine model using hydrodynamic injection to deliver transposon plasmids encoding constitutive YAP and doxycycline (Dox)-inducible Delta N90-beta-Catenin(YAP/TRE-beta-Catenin). Gene expression patterns in mouse HB lesions were analyzed upon short-term Dox withdrawal, that is, tumors still existed but Delta N90-beta-Catenin was turned off. The mice rapidly developed aggressive HB lesions when fed Dox. However, upon Dox withdrawal, HB regressed, although tumors did not completely disappear over a long time. At the molecular level, YAP and beta-Catenin were found to regulate distinct gene expression programs in HB. Specifically, YAP controls the Hippo and metabolism-related pathways, whereas beta-Catenin modulates immune-related pathways, contributing to immune exclusion in the tumor microenvironment. Furthermore, we identified the transcription factor ONECUT1 as a tumor suppressor gene downregulated by activated beta-Catenin in HB. Low ONECUT1 expression also characterizes human HB, and the co-expression of ONECUT1 strongly suppressed YAP/beta-Catenin-driven HB formation in the mice. Mechanistically, ONECUT1 functions downstream of activated beta-Catenin and negatively regulates tumor cell glycolysis.Conclusions:We show that suppressing activated beta-Catenin could hamper HB progression in vivo by affecting pathways distinct from those regulated by YAP in HB. The inhibition of ONECUT1 expression by beta-Catenin might represent a critical molecular event leading to HB formation.

Item Type: Article
Uncontrolled Keywords: WNT/BETA-CATENIN; INTERPLAY; hepatoblastoma; Hippo/YAP; molecular pathogenesis; beta-Catenin
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Pathologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 10 Nov 2026 08:11
Last Modified: 10 Nov 2026 08:11
URI: https://pred.uni-regensburg.de/id/eprint/67184

Actions (login required)

View Item View Item